{
    "organizations": [],
    "uuid": "df5ba3cd7ba1b07723fb1f22ecc461a4b8e94fc4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-elanix-biotechnologies-raises-eur/brief-elanix-biotechnologies-raises-eur-1-1-mln-from-capital-increase-idUSASM000JA2",
    "ord_in_thread": 0,
    "title": "BRIEF-Elanix Biotechnologies Raises EUR 1.1 Mln From Capital Increase",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Elanix Biotechnologies AG:\n* DGAP-ADHOC: ELANIX BIOTECHNOLOGIES AG: ELANIX BIOTECHNOLOGIES AG PLACES A TOTAL OF 300,019 SHARES FROM THE CURRENT CASH CAPITAL INCREASE AND SIGNS A TERM SHEET FOR FINANCING FACILITY OF UP TO EUR 11 MILLION\n* GROSS PROCEEDS OF EUR 1.125 MILLION * SHARES PLACED AT A SUBSCRIPTION PRICE OF EUR 3.75 * ‍SHARE CAPITAL OF ELANIX WILL INCREASE TO A TOTAL OF 7,099,219 SHARES​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-14T18:06:00.000+02:00",
    "crawled": "2018-02-15T20:58:49.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "elanix",
        "biotechnology",
        "ag",
        "elanix",
        "biotechnology",
        "ag",
        "elanix",
        "biotechnology",
        "ag",
        "place",
        "total",
        "share",
        "current",
        "cash",
        "capital",
        "increase",
        "sign",
        "term",
        "sheet",
        "financing",
        "facility",
        "eur",
        "million",
        "gross",
        "proceeds",
        "eur",
        "million",
        "share",
        "placed",
        "subscription",
        "price",
        "eur",
        "capital",
        "elanix",
        "increase",
        "total",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}